Panacea Acquisition Corp II Cl A (PANA)
Panacea Acquisition Corp II Cl A (PANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 70 | 353 | N/A | N/A |
| TOTAL | $208 | $678 | $N/A | $N/A |
| Non-Current Assets | ||||
| Investments And Advances | 174,912 | 172,877 | 0 | 0 |
| TOTAL | $174,912 | $172,877 | $N/A | $N/A |
| Total Assets | $175,120 | $173,555 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accrued Expenses | 434 | 296 | N/A | N/A |
| TOTAL | $434 | $296 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 174,912 | 172,500 | 0 | 0 |
| TOTAL | $180,950 | $178,538 | $N/A | $N/A |
| Total Liabilities | $181,384 | $178,834 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 23,545 | 23,545 | N/A | N/A |
| Common Shares | 1 | 1 | N/A | N/A |
| Retained earnings | -6,264 | -5,279 | N/A | N/A |
| TOTAL | $-6,263 | $-5,279 | $N/A | $N/A |
| Total Liabilities And Equity | $175,120 | $173,555 | $0 | $0 |